[1]
O. Omar Khan, “Efficacy and safety of CTLA-4, PD-1 and LAG-3 immune checkpoint inhibitors as monotherapy and combination therapy in advanced melanoma: A systematic review and meta-analysis”, EXCLI J., vol. 25, pp. 310–329, Jan. 2026.